{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:44:47Z","timestamp":1770295487088,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SIR\/2022\/000019"],"award-info":[{"award-number":["SIR\/2022\/000019"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.pharma.2024.04.006","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T05:55:21Z","timestamp":1713765321000},"page":"830-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of engineered transferosomal gel containing meloxicam for the treatment of osteoarthritis"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6645-9461","authenticated-orcid":false,"given":"Rahul","family":"Maheshwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayank","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay R.","family":"Chidrawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2024.04.006_bib0280","first-page":"e721","article-title":"AAOS clinical practice guideline summary: management of osteoarthritis of the knee (nonarthroplasty)","volume":"30","author":"Brophy","year":"2022","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.pharma.2024.04.006_bib0285","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","article-title":"Synovial inflammation in osteoarthritis progression","volume":"18","author":"Sanchez-Lopez","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0290","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41413-022-00226-9","article-title":"Current understanding of osteoarthritis pathogenesis and relevant new approaches","volume":"10","author":"Tong","year":"2022","journal-title":"Bone Res"},{"key":"10.1016\/j.pharma.2024.04.006_bib0295","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.3390\/ijms23094642","article-title":"Osteoarthritis pain","volume":"23","author":"Yu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharma.2024.04.006_bib0300","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.3390\/jcm11206013","article-title":"Osteoarthritis: new insight on its pathophysiology","volume":"11","author":"Coaccioli","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.pharma.2024.04.006_bib0305","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/art.42089","article-title":"Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019","volume":"74","author":"Long","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0310","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.joca.2021.10.003","article-title":"Osteoarthritis year in review 2021: epidemiology & therapy","volume":"30","author":"Quicke","year":"2022","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.pharma.2024.04.006_bib0315","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-023-01330-w","article-title":"Osteoarthritis: pathogenic signaling pathways and therapeutic targets","volume":"8","author":"Yao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.pharma.2024.04.006_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-021-02705-6","article-title":"Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study","volume":"24","author":"Fu","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pharma.2024.04.006_bib0325","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1016\/S2665-9913(23)00207-2","article-title":"The global burden of osteoarthritis: past and future perspectives","volume":"5","author":"Wong","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0330","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.joca.2022.05.004","article-title":"Burden of osteoarthritis in India and its states, 1990\u20132019: findings from the Global Burden of disease study 2019","volume":"30","author":"Singh","year":"2022","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.pharma.2024.04.006_bib0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41584-021-00695-y","article-title":"Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms","volume":"18","author":"Jansen","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0340","doi-asserted-by":"crossref","first-page":"907750","DOI":"10.3389\/fimmu.2022.907750","article-title":"Obesity, inflammation, and immune system in osteoarthritis","volume":"13","author":"Nedunchezhiyan","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.pharma.2024.04.006_bib0345","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00256-022-04191-6","article-title":"Structural phenotypes of knee osteoarthritis: potential clinical and research relevance","volume":"52","author":"Roemer","year":"2023","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0350","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41584-021-00747-3","article-title":"Erosive hand osteoarthritis: latest findings and outlook","volume":"18","author":"Favero","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0355","doi-asserted-by":"crossref","first-page":"3377680","DOI":"10.1155\/2022\/3377680","article-title":"Evaluation of the Pro-, Anti-Inflammatory, and Anabolic Effects of Autologous Platelet-Rich Gel Supernatants in an in vitro Coculture System of Canine Osteoarthritis","volume":"2022","author":"Gallego","year":"2022","journal-title":"Vet Med Int"},{"key":"10.1016\/j.pharma.2024.04.006_bib0360","doi-asserted-by":"crossref","first-page":"100412","DOI":"10.1016\/j.ocarto.2023.100412","article-title":"Current status of catabolic, anabolic and inflammatory biomarkers associated with structural and symptomatic changes in the chronic phase of post-traumatic knee osteoarthritis\u2013 a systematic review","volume":"5","author":"O'Sullivan","year":"2023","journal-title":"Osteoarthritis Cartil Open"},{"key":"10.1016\/j.pharma.2024.04.006_bib0365","doi-asserted-by":"crossref","first-page":"101373","DOI":"10.1016\/j.eclinm.2022.101373","article-title":"Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"46","author":"Zhou","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.pharma.2024.04.006_bib0370","doi-asserted-by":"crossref","first-page":"112958","DOI":"10.1016\/j.biopha.2022.112958","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: adjusting prescription to patient features","volume":"150","author":"Ribeiro","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharma.2024.04.006_bib0375","doi-asserted-by":"crossref","first-page":"131226","DOI":"10.1016\/j.jclepro.2022.131226","article-title":"Overview of non-steroidal anti-inflammatory drugs degradation by advanced oxidation processes","volume":"346","author":"da Silva","year":"2022","journal-title":"J Clean Prod"},{"key":"10.1016\/j.pharma.2024.04.006_bib0380","doi-asserted-by":"crossref","first-page":"120803","DOI":"10.1016\/j.ijpharm.2021.120803","article-title":"Cationic liposomes mediated transdermal delivery of meloxicam and ketoprofen: optimization of the composition, in vitro and in vivo assessment of efficiency","volume":"605","author":"Kuznetsova","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.04.006_bib0385","first-page":"1","article-title":"The role of exparel plus meloxicam for postoperative pain management","volume":"24","author":"Kaye","year":"2020","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.pharma.2024.04.006_bib0390","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/jvp.13404","article-title":"Age-related changes in the pharmacokinetics of meloxicam after intravenous administration in sheep","volume":"46","author":"Coskun","year":"2023","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.pharma.2024.04.006_bib0395","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.toxlet.2020.11.015","article-title":"Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam","volume":"338","author":"Barnette","year":"2021","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.pharma.2024.04.006_bib0400","doi-asserted-by":"crossref","unstructured":"Nasr Y. Khalil, Khalid F. Aldosari, Chapter Six - Meloxicam, In: Harry G. Brittain (Ed.), Profiles of Drug Substances, Excipients and Related Methodology, Academic Press, Volume 45, 2020, P. 159-197, ISSN 1871-5125, ISBN 9780128203231, https:\/\/doi.org\/10.1016\/bs.podrm.2019.10.006. (https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1871512519300214)X","DOI":"10.1016\/bs.podrm.2019.10.006"},{"key":"10.1016\/j.pharma.2024.04.006_bib0405","doi-asserted-by":"crossref","unstructured":"Dinesh K. Mishra, Vikas Pandey, Rahul Maheshwari, Piyush Ghode, Rakesh K. Tekade, Chapter 15 - Cutaneous and Transdermal Drug Delivery: Techniques and Delivery Systems, Editor(s): Rakesh K. Tekade, In Advances in Pharmaceutical Product Development and Research, Basic Fundamentals of Drug Delivery, Academic Press, 2019, Pages 595-650, ISBN 9780128179093, https:\/\/doi.org\/10.1016\/B978-0-12-817909-3.00015-7.","DOI":"10.1016\/B978-0-12-817909-3.00015-7"},{"key":"10.1016\/j.pharma.2024.04.006_bib0410","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/02652048.2022.2116119","article-title":"\u2018Transfersome-embedded-gel\u2019 for dual-mechanistic delivery of anti-psoriatic drugs to dermal lymphocytes","volume":"39","author":"Todke","year":"2022","journal-title":"J Microencapsul"},{"key":"10.1016\/j.pharma.2024.04.006_bib0415","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2217\/nnm-2022-0069","article-title":"Quality-by-design-based engineered liposomal nanomedicines to treat cancer: an in-depth analysis","volume":"17","author":"Kapoor","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.pharma.2024.04.006_bib0420","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4274\/tjps.galenos.2020.33239","article-title":"Development of an aloe vera-based emulgel for the topical delivery of desoximetasone","volume":"18","author":"Sainy","year":"2021","journal-title":"Turk J Pharm Sci"},{"key":"10.1016\/j.pharma.2024.04.006_bib0425","doi-asserted-by":"crossref","first-page":"8911","DOI":"10.1039\/C8NR01383G","article-title":"Carbon nanotubes (CNTs) based advanced dermal therapeutics: current trends and future potential","volume":"10","author":"Kuche","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.pharma.2024.04.006_bib0430","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1021\/acs.molpharmaceut.3c00126","article-title":"Natural ingredients of transdermal drug delivery systems as permeation enhancers of active substances through the stratum corneum","volume":"20","author":"Schafer","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharma.2024.04.006_bib0435","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1021\/acsmaterialslett.3c01317","article-title":"Transdermal drug delivery system: current status and clinical application of microneedles","volume":"6","author":"Xue","year":"2024","journal-title":"ACS Mater Lett"},{"key":"10.1016\/j.pharma.2024.04.006_bib0440","doi-asserted-by":"crossref","first-page":"111544","DOI":"10.1016\/j.msec.2020.111544","article-title":"Design, characterization, and modeling of a chitosan microneedle patch for transdermal delivery of meloxicam as a pain management strategy for use in cattle","volume":"118","author":"Castilla-Casadiego","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.pharma.2024.04.006_bib0445","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.2147\/IJN.S274954","article-title":"Deformable Liposomal Hydrogel for Dermal and Transdermal Delivery of Meloxicam","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.pharma.2024.04.006_bib0450","doi-asserted-by":"crossref","first-page":"104880","DOI":"10.1016\/j.jddst.2023.104880","article-title":"New insights in aptamer-targeted nanoliposomes for the treatment of breast cancer","volume":"87","author":"Singhai","year":"2023","journal-title":"J Drug Delivery Sci Technol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0455","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jsps.2011.10.001","article-title":"Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment","volume":"20","author":"Maheshwari","year":"2012","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.pharma.2024.04.006_bib0460","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1166\/sam.2015.2245","article-title":"Chitosan encrusted nonionic surfactant based vesicular formulation for topical administration of ofloxacin","volume":"7","author":"Maheshwari","year":"2015","journal-title":"Sci Adv Mater"},{"key":"10.1016\/j.pharma.2024.04.006_bib0465","doi-asserted-by":"crossref","first-page":"16479","DOI":"10.1021\/acsomega.3c01654","article-title":"pH-responsive nano-transferosomes of purpurin-18 sodium salt and doxorubicin for enhanced anticancer efficiency by photodynamic and chemo combination therapy","volume":"8","author":"Yeo","year":"2023","journal-title":"ACS omega"},{"key":"10.1016\/j.pharma.2024.04.006_bib0470","doi-asserted-by":"crossref","first-page":"43290","DOI":"10.1021\/acsomega.2c06215","article-title":"Intranasally co-administered berberine and curcumin loaded in transfersomal vesicles improved inhibition of amyloid formation and BACE-1","volume":"7","author":"Mishra","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.pharma.2024.04.006_bib0475","doi-asserted-by":"crossref","first-page":"1006628","DOI":"10.3389\/fnano.2022.1006628","article-title":"Localized topical drug delivery systems for skin cancer: current approaches and future prospects","volume":"4","author":"Gupta","year":"2022","journal-title":"Front Nanotechnol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0480","doi-asserted-by":"crossref","first-page":"118817","DOI":"10.1016\/j.ijpharm.2019.118817","article-title":"Transferosomes as nanocarriers for drugs across the skin: quality by design from lab to industrial scale","volume":"573","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.04.006_bib0485","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/1567201817666200804105416","article-title":"Transfersomes: the ultra-deformable carrier system for non-invasive delivery of drug","volume":"18","author":"Gupta","year":"2021","journal-title":"Curr Drug Del"},{"key":"10.1016\/j.pharma.2024.04.006_bib0490","doi-asserted-by":"crossref","first-page":"850862","DOI":"10.3389\/fphar.2022.850862","article-title":"Phytochemical delivery through transferosome (phytosome): an advanced transdermal drug delivery for complementary medicines","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0495","doi-asserted-by":"crossref","unstructured":"Potisuwan S., Apichatwatana N., Rujivipat S. Improved skin permeation of transferosomes containing Eulophia macrobulbon extract. Coll Surf B Biointerf 2023;229:113474. doi:10.1016\/j.colsurfb.2023.113474. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0927776523003521 [ISSN 0927-7765]","DOI":"10.1016\/j.colsurfb.2023.113474"},{"key":"10.1016\/j.pharma.2024.04.006_bib0500","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2217\/nnm-2023-0069","article-title":"Quality-by-design-based development of ultradeformable nanovesicular transgelosome of standardized Piper longum extract for melanoma","volume":"18","author":"Mohapatra","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.pharma.2024.04.006_bib0505","doi-asserted-by":"crossref","first-page":"122274","DOI":"10.1016\/j.ijpharm.2022.122274","article-title":"Employment of PEGylated ultra-deformable transferosomes for transdermal delivery of tapentadol with boosted bioavailability and analgesic activity in post-surgical pain","volume":"628","author":"Deng","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.04.006_bib0510","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/pharmaceutics15020533","article-title":"Investigating the targeting power to brain tissues of intranasal rasagiline mesylate-loaded transferosomal in situ gel for efficient treatment of Parkinson's disease","volume":"15","author":"ElShagea","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2024.04.006_bib0515","doi-asserted-by":"crossref","first-page":"106267","DOI":"10.1016\/j.ejps.2022.106267","article-title":"How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition\u00a0\u2013\u00a0a formulation screening study","volume":"177","author":"Hols\u00e6ter","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharma.2024.04.006_bib0520","first-page":"100059","article-title":"Flavonoid-liposomes formulations: physico-chemical characteristics, biological activities and therapeutic applications","volume":"5","author":"Halevas","year":"2022","journal-title":"Eur J Med Chem Rep"},{"key":"10.1016\/j.pharma.2024.04.006_bib0525","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0530","doi-asserted-by":"crossref","first-page":"105287","DOI":"10.1016\/j.jddst.2023.105287","article-title":"Comparative pharmacokinetic studies of transferosomes loaded gel and pressure sensitive adhesive based patch formulation for transdermal delivery of benztropine mesylate","volume":"92","author":"Chabru","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0535","doi-asserted-by":"crossref","first-page":"213777","DOI":"10.1016\/j.bioadv.2024.213777","article-title":"Lab on chip based self-adjustable liposomes for rapid wound healing: An in depth in vitro, in vivo and higher dose toxicity investigation","volume":"158","author":"Maheshwari","year":"2024","journal-title":"Biomater Adv"},{"key":"10.1016\/j.pharma.2024.04.006_bib0540","doi-asserted-by":"crossref","first-page":"102313","DOI":"10.1016\/j.jddst.2020.102313","article-title":"Design, evaluation and in vivo pharmacokinetic study of a cationic flexible liposomes for enhanced transdermal delivery of pramipexole","volume":"61","author":"Trivedi","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2024.04.006_bib0545","doi-asserted-by":"crossref","first-page":"123144","DOI":"10.1016\/j.ijpharm.2023.123144","article-title":"Localized delivery of Erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinoma","volume":"642","author":"Hariharan","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.04.006_bib0550","doi-asserted-by":"crossref","first-page":"122129","DOI":"10.1016\/j.ijpharm.2022.122129","article-title":"Pentoxifylline\/valsartan co-delivery in liposomal gel alters the inflammatory HMGB-1\/TLR pathway and promotes faster healing in burn wounds: a promising repurposed approach","volume":"625","author":"El-Salamouni","year":"2022","journal-title":"Int J Pharm"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:34:02Z","timestamp":1724963642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0003450924000634"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.04.006","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of engineered transferosomal gel containing meloxicam for the treatment of osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}